Institutional Ownership Centessa Pharmaceuticals PLC (CNTA)
This table provides information about the institutional ownership of Centessa Pharmaceuticals PLC (CNTA). We have compiled data on the 118 institutions that hold shares in the stock, with a total of 124 Million shares, which have been reported (via 13F filing form) to have a value of $1.97 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Medicxi Ventures Management (Jersey) LTD
|
Jan 23, 2025 Q4 2024 |
19,963,157
shares
|
$334 Million
73.44% of portfolio
|
Q1 2022
Added 10.15%
|
|
|
Index Venture Life Associates Vi LTD
St. Helier, Y9 |
Feb 14, 2025 Q4 2024 |
9,961,789
shares
|
$167 Million
99.89% of portfolio
|
Q4 2021
New holding
|
|
|
General Atlantic LLC
New York, NY |
Feb 07, 2025 Q4 2024 |
9,681,818
shares
|
$162 Million
5.81% of portfolio
|
Q3 2021
Added 545.45%
|
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
6,349,220
shares
|
$106 Million
3.55% of portfolio
|
Q4 2024
Added 1.07%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Feb 14, 2025 Q4 2024 |
5,805,184
shares
|
$97.2 Million
9.51% of portfolio
|
Q4 2024
Reduced 2.27%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
5,364,392
shares
|
$89.9 Million
0.01% of portfolio
|
Q4 2024
Added 14.65%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
5,119,027
shares
|
$85.7 Million
0.16% of portfolio
|
Q4 2024
Added 22.03%
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,909,487
shares
|
$82.2 Million
0.04% of portfolio
|
Q4 2024
Added 279.15%
|
|
|
Vida Ventures Advisors, LLC
|
Jan 21, 2025 Q4 2024 |
3,931,818
shares
|
$65.9 Million
80.4% of portfolio
|
Q2 2021
New holding
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,498,709
shares
|
$58.6 Million
0.31% of portfolio
|
Q4 2024
Added 24.32%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
3,426,599
shares
|
$57.4 Million
0.14% of portfolio
|
Q4 2024
Added 26.18%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,418,600
shares
|
$57.3 Million
0.04% of portfolio
|
Q4 2024
Reduced 3.86%
|
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
3,004,677
shares
|
$50.3 Million
2.22% of portfolio
|
Q4 2024
Reduced 7.79%
|
|
|
Oup Management Co., LLC
|
Nov 09, 2023 Q3 2023 |
2,937,615
shares
|
$49.2 Million
42.75% of portfolio
|
Q1 2022
Added 25.44%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
2,890,816
shares
|
$48.4 Million
7.91% of portfolio
|
Q2 2024
Added 41.65%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,561,600
shares
|
$42.9 Million
3.39% of portfolio
|
Q3 2024
Added 58.95%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
2,308,546
shares
|
$38.7 Million
0.01% of portfolio
|
Q4 2024
Added 0.26%
|
|
|
Commodore Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,218,425
shares
|
$37.2 Million
3.72% of portfolio
|
Q4 2024
Added 64.33%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,993,052
shares
|
$33.4 Million
7.44% of portfolio
|
Q4 2024
Reduced 0.94%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,924,509
shares
|
$32.2 Million
0.0% of portfolio
|
Q4 2024
Added 39.49%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,598,183
shares
|
$26.8 Million
0.26% of portfolio
|
Q4 2024
Reduced 26.07%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,350,000
shares
|
$22.6 Million
1.0% of portfolio
|
Q3 2024
New holding
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Feb 14, 2025 Q4 2024 |
1,253,379
shares
|
$21 Million
9.35% of portfolio
|
Q4 2024
New holding
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,227,178
shares
|
$20.6 Million
0.23% of portfolio
|
Q3 2024
Added 123.44%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
1,165,800
shares
|
$19.5 Million
2.21% of portfolio
|
Q4 2024
Reduced 45.32%
|